ONCOMATRYX
Develops Quantum ADCs against the tumor microenvironment for metastatic solid tumors
$67MSeries B
Role not disclosedLoading investors…
Activity from announced rounds
Develops Quantum ADCs against the tumor microenvironment for metastatic solid tumors